Twenty‐four‐hour intraocular pressure measurement in glaucoma

By  

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 43, Iss. 9, 2015-12 ,pp. : 782-783

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension

By Katz L. Jay   Simmons Steven T.   Craven E. Randy  

Current Medical Research and Opinion, Vol. 23, Iss. 12, 2007-12 ,pp. : 2971-2983

Informa Healthcare

Access to resources Recommend Favorite

Changes in intraocular pressure following a switch from latanoprost monotherapy to latanoprost/timolol fixed combination therapy in patients with primary open-angle glaucoma or ocular hypertension: results from a clinical practice database

By Lazaridou Marie-Noëlle   Montgomery Donald M. I.   Ho Whye Onn   Jaberoo David  

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2725-2728

Informa Healthcare

Access to resources Recommend Favorite

Influence of switching to travoprost on intraocular pressure of uncontrolled chronic open-angle glaucoma patients compliant to previously-used topical medication

By Holló Gábor   Vargha Péter   Kóthy Péter  

Current Medical Research and Opinion, Vol. 21, Iss. 12, 2005-12 ,pp. : 1943-1948

Informa Healthcare

Access to resources Recommend Favorite

Intraocular pressure lowering effect of dorzolamide/timolol fixed combination in patients with glaucoma who were unresponsive to prostaglandin analogs/prostamides

By Martínez Antonio   Sánchez Manuel  

Current Medical Research and Opinion, Vol. 23, Iss. 3, 2007-03 ,pp. : 595-599

Informa Healthcare

Access to resources Recommend Favorite